Stay updated with the latest nucleic-acid news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on nucleic-acid topics.
Cohance Lifesciences will be investing ₹23 crore (₹230 million) in its new Current Good Manufacturing Practice (cGMP) oligonucleotide building block manufacturing facility in Hyderabad. "Oligonucleotides are a fast-emerging therapeutic class, and innovators are seeking integrated, cost-efficient partners with scalable GMP capacity. This facility is a high-impact strategic investment that complements our pilot and scale-up assets, positioning Cohance to deliver with speed, quality and flexibi ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.